Diesel exposure favors Th2 cell recruitment by mononuclear cells and alveolar macrophages from allergic patients by differentially regulating macrophage-derived chemokine and IFN-gamma-induced protein-10 production

J Immunol. 2002 Jun 1;168(11):5912-9. doi: 10.4049/jimmunol.168.11.5912.

Abstract

Diesel exhausts and their associated organic compounds may be involved in the recent increase in the prevalence of allergic disorders, through their ability to favor a type 2 immune response. Type 2 T cells have been shown to be preferentially recruited by the chemokines eotaxin (CCL11), macrophage-derived chemokine (MDC, CCL22), and thymus activation-regulated chemokine (CCL17) through their interaction with CCR3 and CCR4, respectively, whereas type 1 T cells are mainly recruited by IFN-gamma-induced protein-10 (CXCL10) through CXCR3 binding. The aim of the study was to evaluate the effect of diesel exposure on the expression of chemokines involved in type 1 and 2 T cell recruitment. PBMC and alveolar macrophages from house dust mite allergic patients were incubated with combinations of diesel extracts and Der p 1 allergen, and chemokine production was analyzed. Diesel exposure alone decreased the constitutive IP-10 production, while it further augmented allergen-induced MDC production, resulting in a significantly increased capacity to chemoattract human Th2, but not Th1 clones. Inhibition experiments with anti-type 1 or type 2 cytokine Abs as well as cytokine mRNA kinetic evaluation showed that the chemokine variations were not dependent upon IL-4, IL-13, or IFN-gamma expression. In contrast, inhibition of the B7:CD28 pathway using a CTLA-4-Ig fusion protein completely inhibited diesel-dependent increase of allergen-induced MDC production. This inhibition was mainly dependent upon the CD86 pathway and to a lesser extent upon the CD80 pathway. These results suggest that the exposure to diesel exhausts and allergen may likely amplify a deleterious type 2 immune response via a differential regulation of chemokine production through the CD28 pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Dermatophagoides
  • B7-1 Antigen / physiology
  • CD28 Antigens / physiology
  • Chemokine CCL22
  • Chemokine CXCL10
  • Chemokines / biosynthesis
  • Chemokines / genetics
  • Chemokines, CC / biosynthesis*
  • Chemokines, CXC / biosynthesis*
  • Chemotaxis, Leukocyte
  • Glycoproteins / immunology
  • Humans
  • Hypersensitivity / immunology*
  • Leukocytes, Mononuclear / physiology*
  • Macrophages, Alveolar / physiology*
  • RNA, Messenger / analysis
  • Receptors, Chemokine / genetics
  • Th2 Cells / immunology*
  • Vehicle Emissions / adverse effects*

Substances

  • Antigens, Dermatophagoides
  • B7-1 Antigen
  • CCL22 protein, human
  • CD28 Antigens
  • Chemokine CCL22
  • Chemokine CXCL10
  • Chemokines
  • Chemokines, CC
  • Chemokines, CXC
  • Glycoproteins
  • RNA, Messenger
  • Receptors, Chemokine
  • Vehicle Emissions